Stefan Angermair
Overview
Explore the profile of Stefan Angermair including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
660
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Omran S, Schawe L, Konietschke F, Angermair S, Weixler B, Treskatsch S, et al.
J Clin Med
. 2023 Jun;
12(12).
PMID: 37373851
(1) Background: This retrospective study evaluated perioperative and intensive care unit (ICU) variables to predict colonic ischemia (CI) after infrarenal ruptured abdominal aortic aneurysm (RAAA) surgery. (2) Materials and Methods:...
12.
Bayerl C, Berg A, Angermair S, Kim D, Hamm B, Beyer K, et al.
Front Med (Lausanne)
. 2023 Jun;
10:1164466.
PMID: 37265483
Emphysematous diseases of the abdomen are rare with an often inconspicuous presentation of symptoms and rapid lethal outcome if untreated. We report the first successfully treated case of -associated emphysematous...
13.
Schellenberg C, Lindholz M, Grunow J, Boie S, Bald A, Warner L, et al.
Anaesth Crit Care Pain Med
. 2023 May;
42(5):101255.
PMID: 37257753
Background: Corona Virus Disease 2019 (COVID-19) patients display risk factors for intensive care unit acquired weakness (ICUAW). The pandemic increased existing barriers to mobilisation. This study aimed to compare mobilisation...
14.
Angermair S, Deja M, Thronicke A, Grehn C, Akbari N, Uhrig A, et al.
Anaesth Crit Care Pain Med
. 2023 May;
42(5):101249.
PMID: 37217019
Objective: Treatment of ventilated pneumonia is often unsuccessful, even when patients are treated according to current guidelines. Therefore, we aimed to investigate the efficacy of the adjunctive inhaled Tobramycin in...
15.
Felder S, Fischer P, Bohler K, Angermair S, Treskatsch S, Witte W
Anasthesiol Intensivmed Notfallmed Schmerzther
. 2023 Mar;
58(3):183-193.
PMID: 36958314
The transplantation of organs from postmortem organ donors has been a lifesaving and quality-of-life-improving therapy for patients with irreversible organ failure for many years. In Germany, however, there has been...
16.
Lindholz M, Schellenberg C, Grunow J, Kagerbauer S, Milnik A, Zickler D, et al.
Crit Care
. 2022 Nov;
26(1):362.
PMID: 36434724
Background: Mobilisation and exercise intervention in general are safe and feasible in critically ill patients. For patients requiring catecholamines, however, doses of norepinephrine safe for mobilisation in the intensive care...
17.
Haibel H, Poddubnyy D, Angermair S, Allers K, Vahldiek J, Schumann M, et al.
Ther Adv Musculoskelet Dis
. 2022 Sep;
14:1759720X221116405.
PMID: 36071720
Interleukin (IL)-6 and IL-1 blockade showed beneficial results in patients with severe COVID-19 pneumonia and evidence of cytokine release at the early disease stage. Here, we report outcomes of open-label...
18.
Wolter E, Treskatsch S, Kniesel O, Berger C, Angermair S
Anaesthesiologie
. 2022 Aug;
71(Suppl 1):93-96.
PMID: 35925177
No abstract available.
19.
Hegazy A, Kronke J, Angermair S, Schwartz S, Weidinger C, Keller U, et al.
BMC Infect Dis
. 2022 Jun;
22(1):537.
PMID: 35692034
Background: Passive immunization against SARS-CoV-2 limits viral burden and death from COVID-19; however, it poses a theoretical risk of disease exacerbation through antibody-dependent enhancement (ADE). ADE after anti-SARS-CoV2 antibody treatment...
20.
Huo S, Ferse C, Bosl F, Reincke S, Enghard P, Hinrichs C, et al.
J Neurol
. 2022 May;
269(8):4013-4020.
PMID: 35538168
No abstract available.